In conclusion, we have demonstrated that alpinetin inhibit the proliferation and viability of pancreatic cancer cells in a dose- and time-dependent manner through regulating Bcl-2 family and XIAP expression, releasing of cytochrome c and activation of caspases. This evidence concerns the gene CYCS and familial pancreatic carcinoma.